EUVIMEDEUVIMED entdecken
Crossref

Sodium–Glucose Cotransporter 2 Inhibitors in Dialysis

Zena Barakat iD, Benjamin Lazarus

Clinical Journal of the American Society of Nephrology · 10.11.2026

DOI: 10.2215/cjn.0000001274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 10.11.2026. Verfasst von Zena Barakat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Monash Health, Clayton, Victoria, Australia. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ESKDSGLT2 inhibitorsclinical trialdialysisheart failurehemodialysiskidney failurerandomized controlled trials

Autor:innen und Institutionen

  • Department of Nephrology, Monash Health, Clayton, Victoria, Australia.
  • Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
  • Department of Nephrology, Princess Alexandra Hospital, Queensland, Australia.
  • Frazer Institute, University of Queensland, Queensland, Australia.

ORCID-Profile: Zena Barakat

Zitieren

APA

Barakat, Z., & Lazarus, B. (2026). Sodium–Glucose Cotransporter 2 Inhibitors in Dialysis. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001274

Vancouver

Barakat Z, Lazarus B. Sodium–Glucose Cotransporter 2 Inhibitors in Dialysis. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001274

BibTeX
@article{Barakat2026,
  author = {Barakat, Zena and Lazarus, Benjamin},
  title = {Sodium–Glucose Cotransporter 2 Inhibitors in Dialysis},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001274}
}
Kostenlos starten →